Becton Dickinson & Co (BDX) SEC filings

BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3015% above fair value

$215.71+1.19 (+0.55%)

Close on Nov 12, 2026Market cap $58.76BP/E 65.2Yield 1.93%

SEC filings

40 of Becton Dickinson's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	8-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Aug 6, 2026	Aug 6, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 6, 2026	SEC EDGAR
Current report	8-K	Jul 19, 2026	Jul 22, 2026	SEC EDGAR
Current report	8-K	May 29, 2026	May 29, 2026	SEC EDGAR
Current report	8-K	May 20, 2026	May 20, 2026	SEC EDGAR
Current report	8-K	May 11, 2026	May 12, 2026	SEC EDGAR
Current report	8-K	May 7, 2026	May 7, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 7, 2026	SEC EDGAR
Current report	8-K	Apr 28, 2026	Apr 29, 2026	SEC EDGAR
Current report	8-K	Apr 6, 2026	Apr 9, 2026	SEC EDGAR
Current report	8-K	Apr 2, 2026	Apr 2, 2026	SEC EDGAR
Current report	8-K	Feb 25, 2026	Feb 25, 2026	SEC EDGAR
Current report	8-K	Feb 10, 2026	Feb 10, 2026	SEC EDGAR
Current report	8-K	Feb 9, 2026	Feb 9, 2026	SEC EDGAR
Current report	8-K	Feb 9, 2026	Feb 9, 2026	SEC EDGAR
Quarterly report	10-Q	Dec 31, 2025	Feb 9, 2026	SEC EDGAR
Current report	8-K	Feb 5, 2026	Feb 5, 2026	SEC EDGAR
Current report	8-K	Jan 30, 2026	Feb 5, 2026	SEC EDGAR
Current report	8-K	Jan 27, 2026	Jan 30, 2026	SEC EDGAR
Current report	8-K	Dec 30, 2025	Jan 6, 2026	SEC EDGAR
Proxy statement	DEF 14A	Dec 12, 2025	Dec 18, 2025	SEC EDGAR
Annual report	10-K	Sep 30, 2025	Nov 25, 2025	SEC EDGAR
Current report	8-K	Nov 17, 2025	Nov 17, 2025	SEC EDGAR
Current report	8-K	Nov 6, 2025	Nov 6, 2025	SEC EDGAR
Current report	8-K	Oct 9, 2025	Oct 15, 2025	SEC EDGAR
Current report	8-K	Sep 16, 2025	Sep 18, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 7, 2025	SEC EDGAR
Current report	8-K	Aug 7, 2025	Aug 7, 2025	SEC EDGAR
Current report	8-K	Jul 13, 2025	Jul 14, 2025	SEC EDGAR
Current report	8-K	Jul 14, 2025	Jul 14, 2025	SEC EDGAR
Current report	8-K	Jun 16, 2025	Jun 16, 2025	SEC EDGAR
Current report	8-K	Apr 29, 2025	May 2, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 1, 2025	SEC EDGAR
Current report	8-K	May 1, 2025	May 1, 2025	SEC EDGAR
Current report	8-K	Mar 26, 2025	Mar 27, 2025	SEC EDGAR
Quarterly report	10-Q	Dec 31, 2024	Feb 6, 2025	SEC EDGAR
Current report	8-K	Feb 5, 2025	Feb 5, 2025	SEC EDGAR
Current report	8-K	Jan 28, 2025	Jan 31, 2025	SEC EDGAR
Current report	8-K	Jan 10, 2025	Jan 10, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Becton Dickinson's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Aug 21, 1998
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BDX.

Compare: BDX vs BSX · BDX vs BAX · BDX vs MDLN · BDX vs SYK · BDX vs MMM

Revenue growth17.4% · median 6.6%

Gross margin46.9% · median 39.5%

Operating margin10.7% · median 18.7%

Net margin4.0% · median 13.8%

Company	Revenue	Growth
MDLN	$30.68B	–
SYK	$26.30B	+7.9%
MMM	$25.25B	+1.7%
BDX	$23.25B	+17.4%
BSX	$21.07B	+8.9%
BAX	$11.61B	+5.3%

Company

Next earnings (est.): Feb 8, 2027, before open
Exchange: NYSE
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: September 30
Employees: 72,000
Held by institutions: 100.0%
Auditor: ERNST& YOUNG LLP
SEC CIK: 10795

Advertisement
300 × 250

See a number that looks wrong?